This week's Lab Notes has items on a Wayne drug developer's expanded partnership for a potential rare skin disease treatment, a Malvern medical technology company's expanded regulatory approval overseas and more.
This week's Lab Notes has items on a Wayne drug developer's expanded partnership for a potential rare skin disease treatment, a Malvern medical technology company's expanded regulatory approval overseas and more.
